Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taku Aoki

Showing results (141-150 of 205) with videos related to

Pageof 21
Sort By:
Surgical Case Reports|April 26, 2019
A technique for taping inferior vena cava caudal to the duodenum: duodenal penetration by IVC filter strut after retroperitoneal lymph node dissection-usefulness of the mesenteric approachTakayuki Shimizu, Keiichi Kubota, Takashi Suzuki, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 23, 2020
Optimal strategy of systemic treatment for unresectable pancreatic neuroendocrine tumors based upon opinion of Japanese expertsMasafumi Ikeda, Chigusa Morizane, Susumu Hijioka, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|October 24, 2014
Use of simeprevir following pre-emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12-week pilot studyTomohiro Tanaka, Yasuhiko Sugawara, Nobuhisa Akamatsu, et al.
Annals of Surgery|March 13, 2013
Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide surveyTaku Aoki, Norihiro Kokudo, Yutaka Matsuyama, et al.
International Immunology|March 29, 2020
PD-L1 is induced on the hepatocyte surface via CKLF-like MARVEL transmembrane domain-containing protein 6 up-regulation by the anti-HBV drug EntecavirYuichiro Yamamoto, Masatoshi Kakizaki, Takayuki Shimizu, et al.
Annals of Surgery|April 17, 2010
Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastasesYoshihiro Mise, Hiroshi Imamura, Takuya Hashimoto, et al.
Molecular and Clinical Oncology|October 15, 2021
Significance of cytoplasmic expression of telomerase reverse transcriptase in patients with hepatocellular carcinoma undergoing liver resectionYusuke Nishi, Taku Aoki, Takayuki Shimizu, et al.
Anticancer Research|July 5, 2020
Features of Hepatocellular Carcinoma With Micro Hepatic Vein Invasion and their Correlation With Hepatitis B and C VirusYuhki Sakuraoka, Keiichi Kubota, Genki Tanaka, et al.
Annals of Surgical Oncology|June 23, 2025
Novel Risk Score Incorporating Type-IV Collagen, Albumin, and Prothrombin Time (CAP score) to Predict 180-Day Surgery-Related Mortality After Liver Resection for Hepatocellular CarcinomaTomoaki Hayakawa, Shotaro Miyashita, Maiko Niki, et al.
Surgery Today|March 29, 2025
Clinical relevance of the red blood cell distribution width measured preoperatively as a prognostic marker in patients with distal cholangiocarcinoma undergoing pancreaticoduodenectomyMaiko Niki, Shozo Mori, Shotaro Miyashita, et al.
Pageof 21

Showing results (141-150 of 205) with videos related to

Sort By:
Pageof 21
Surgical Case Reports|April 26, 2019
A technique for taping inferior vena cava caudal to the duodenum: duodenal penetration by IVC filter strut after retroperitoneal lymph node dissection-usefulness of the mesenteric approachTakayuki Shimizu, Keiichi Kubota, Takashi Suzuki, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 23, 2020
Optimal strategy of systemic treatment for unresectable pancreatic neuroendocrine tumors based upon opinion of Japanese expertsMasafumi Ikeda, Chigusa Morizane, Susumu Hijioka, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|October 24, 2014
Use of simeprevir following pre-emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12-week pilot studyTomohiro Tanaka, Yasuhiko Sugawara, Nobuhisa Akamatsu, et al.
Annals of Surgery|March 13, 2013
Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide surveyTaku Aoki, Norihiro Kokudo, Yutaka Matsuyama, et al.
International Immunology|March 29, 2020
PD-L1 is induced on the hepatocyte surface via CKLF-like MARVEL transmembrane domain-containing protein 6 up-regulation by the anti-HBV drug EntecavirYuichiro Yamamoto, Masatoshi Kakizaki, Takayuki Shimizu, et al.
Annals of Surgery|April 17, 2010
Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastasesYoshihiro Mise, Hiroshi Imamura, Takuya Hashimoto, et al.
Molecular and Clinical Oncology|October 15, 2021
Significance of cytoplasmic expression of telomerase reverse transcriptase in patients with hepatocellular carcinoma undergoing liver resectionYusuke Nishi, Taku Aoki, Takayuki Shimizu, et al.
Anticancer Research|July 5, 2020
Features of Hepatocellular Carcinoma With Micro Hepatic Vein Invasion and their Correlation With Hepatitis B and C VirusYuhki Sakuraoka, Keiichi Kubota, Genki Tanaka, et al.
Annals of Surgical Oncology|June 23, 2025
Novel Risk Score Incorporating Type-IV Collagen, Albumin, and Prothrombin Time (CAP score) to Predict 180-Day Surgery-Related Mortality After Liver Resection for Hepatocellular CarcinomaTomoaki Hayakawa, Shotaro Miyashita, Maiko Niki, et al.
Surgery Today|March 29, 2025
Clinical relevance of the red blood cell distribution width measured preoperatively as a prognostic marker in patients with distal cholangiocarcinoma undergoing pancreaticoduodenectomyMaiko Niki, Shozo Mori, Shotaro Miyashita, et al.
Pageof 21